1964515-43-2 (LDH-IN-1,LDH-IN-1)

化合物LDH-IN-1;

LDH-IN-1;LDH inhibitor 1;4-Thiazolecarboxylic acid, 2-[4-[[4-(aminosulfonyl)phenyl]methyl]-3-[1,1'-biphenyl]-3-yl-5-(cyclopropylmethyl)-1H-pyrazol-1-yl]-;NCGC00372530-01;CS-0034239;NCGC00372530;US10961200, Compound 276;BDBM488897;9YA;CHEMBL4081890;BDBM50250656;SCHEMBL24066023;2-[5-(cyclopropylmethyl)-3-(3-phenylphenyl)-4-[(4-sulfamoylphenyl)methyl]pyrazol-1-yl]-1,3-thiazole-4-carboxylic acid;2-{3-([1,1'-biphenyl]-3-yl)-5-(cyclopropylmethyl)-4-[(4-sulfamoylphenyl)methyl]-1H-pyrazol-1-yl}-1,3-thiazole-4-carboxylic acid;MS-30307;AKOS040733585;G16306;HY-111108;2-(3-{[1,1'-biphenyl]-3-yl}-5-(cyclopropylmethyl)-4-[(4-sulfamoylphenyl)methyl]pyrazol-1-yl)-1,3-thiazole-4-carboxylic acid;DA-64901;1964515-43-2;

ALJORCZKMBZYCR-UHFFFAOYSA-N

1S/C30H26N4O4S2/c31-40(37,38)24-13-11-19(12-14-24)15-25-27(16-20-9-10-20)34(30-32-26(18-39-30)29(35)36)33-28(25)23-8-4-7-22(17-23)21-5-2-1-3-6-21/h1-8,11-14,17-18,20H,9-10,15-16H2,(H,35,36)(H2,31,37,38)

S1C=C(C(O)=O)N=C1N1C(CC2CC2)=C(CC2=CC=C(S(N)(=O)=O)C=C2)C(C2C=CC=C(C3=CC=CC=C3)C=2)=N1